A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.

MLA

Fan, QiWen, et al. “A Kinase Inhibitor Targeted to MTORC1 Drives Regression in Glioblastoma.” Cancer Cell, vol. 31, no. 3, Mar. 2017, pp. 424–35. EBSCOhost, https://doi.org/10.1016/j.ccell.2017.01.014.

APA

Fan, Q., Aksoy, O., Wong, R. A., Ilkhanizadeh, S., Novotny, C. J., Gustafson, W. C., Truong, A. Y.-Q., Cayanan, G., Simonds, E. F., Haas-Kogan, D., Phillips, J. J., Nicolaides, T., Okaniwa, M., Shokat, K. M., & Weiss, W. A. (2017). A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Cancer Cell, 31(3), 424–435. https://doi.org/10.1016/j.ccell.2017.01.014

Chicago

Fan, QiWen, Ozlem Aksoy, Robyn A Wong, Shirin Ilkhanizadeh, Chris J Novotny, William C Gustafson, Albert Yi-Que Truong, et al. 2017. “A Kinase Inhibitor Targeted to MTORC1 Drives Regression in Glioblastoma.” Cancer Cell 31 (3): 424–35. doi:10.1016/j.ccell.2017.01.014.